These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 31620652)

  • 1. Effect of alcohol consumption on nonalcoholic fatty liver disease.
    Weng G; Dunn W
    Transl Gastroenterol Hepatol; 2019; 4():70. PubMed ID: 31620652
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modest alcohol consumption is associated with decreased prevalence of steatohepatitis in patients with non-alcoholic fatty liver disease (NAFLD).
    Dunn W; Sanyal AJ; Brunt EM; Unalp-Arida A; Donohue M; McCullough AJ; Schwimmer JB
    J Hepatol; 2012 Aug; 57(2):384-91. PubMed ID: 22521357
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of Nonalcoholic Steatohepatitis-Associated Cirrhosis in the United States: An Analysis of National Health and Nutrition Examination Survey Data.
    Kabbany MN; Conjeevaram Selvakumar PK; Watt K; Lopez R; Akras Z; Zein N; Carey W; Alkhouri N
    Am J Gastroenterol; 2017 Apr; 112(4):581-587. PubMed ID: 28195177
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Among Patients With Nonalcoholic Fatty Liver Disease, Modest Alcohol Use Is Associated With Less Improvement in Histologic Steatosis and Steatohepatitis.
    Ajmera V; Belt P; Wilson LA; Gill RM; Loomba R; Kleiner DE; Neuschwander-Tetri BA; Terrault N;
    Clin Gastroenterol Hepatol; 2018 Sep; 16(9):1511-1520.e5. PubMed ID: 29378307
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is moderate alcohol use in nonalcoholic fatty liver disease good or bad? A critical review.
    Ajmera VH; Terrault NA; Harrison SA
    Hepatology; 2017 Jun; 65(6):2090-2099. PubMed ID: 28100008
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical epidemiology and disease burden of nonalcoholic fatty liver disease.
    Perumpail BJ; Khan MA; Yoo ER; Cholankeril G; Kim D; Ahmed A
    World J Gastroenterol; 2017 Dec; 23(47):8263-8276. PubMed ID: 29307986
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The relationship between alcohol consumption and chronic kidney disease in patients with nonalcoholic fatty liver disease.
    Zheng T; Wang X; Kamili K; Luo C; Hu Y; Wang D; Wang B; Gao P; Tian G
    Scand J Gastroenterol; 2024 Apr; 59(4):480-488. PubMed ID: 38179969
    [No Abstract]   [Full Text] [Related]  

  • 8. The effect of moderate alcohol drinking in nonalcoholic fatty liver disease.
    Choi JH; Sohn W; Cho YK
    Clin Mol Hepatol; 2020 Oct; 26(4):662-669. PubMed ID: 32971586
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Type and Pattern of Alcohol Consumption is Associated With Liver Fibrosis in Patients With Non-alcoholic Fatty Liver Disease.
    Mitchell T; Jeffrey GP; de Boer B; MacQuillan G; Garas G; Ching H; Hamdorf J; Adams LA
    Am J Gastroenterol; 2018 Oct; 113(10):1484-1493. PubMed ID: 29899440
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [An interpretation of the AASLD practice guideline on the diagnosis and management of nonalcoholic fatty liver disease in 2017].
    Nan YM; Fu N; Li WC; Kong LL; Yuan XW; Zhang SY; Liu LD; Lu Y; Cui LY
    Zhonghua Gan Zang Bing Za Zhi; 2017 Sep; 25(9):687-694. PubMed ID: 29108191
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potential Therapeutic Application of Estrogen in Gender Disparity of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis.
    Lee C; Kim J; Jung Y
    Cells; 2019 Oct; 8(10):. PubMed ID: 31619023
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Meta-analysis: The impact of light-to-moderate alcohol consumption on progressive non-alcoholic fatty liver disease.
    Magherman L; Van Parys R; Pauwels NS; Verhelst X; Devisscher L; Van Vlierberghe H; Geerts A; Lefere S
    Aliment Pharmacol Ther; 2023 Apr; 57(8):820-836. PubMed ID: 36708129
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes.
    Younossi ZM; Koenig AB; Abdelatif D; Fazel Y; Henry L; Wymer M
    Hepatology; 2016 Jul; 64(1):73-84. PubMed ID: 26707365
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatic transcriptome signatures in patients with varying degrees of nonalcoholic fatty liver disease compared with healthy normal-weight individuals.
    Suppli MP; Rigbolt KTG; Veidal SS; Heebøll S; Eriksen PL; Demant M; Bagger JI; Nielsen JC; Oró D; Thrane SW; Lund A; Strandberg C; Kønig MJ; Vilsbøll T; Vrang N; Thomsen KL; Grønbæk H; Jelsing J; Hansen HH; Knop FK
    Am J Physiol Gastrointest Liver Physiol; 2019 Apr; 316(4):G462-G472. PubMed ID: 30653341
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of Alcohol Consumption on Survival in Nonalcoholic Fatty Liver Disease: A National Prospective Cohort Study.
    Hajifathalian K; Torabi Sagvand B; McCullough AJ
    Hepatology; 2019 Aug; 70(2):511-521. PubMed ID: 30125379
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-alcoholic Fatty Liver Disease and Alcohol-Related Liver Disease: Two Intertwined Entities.
    Idalsoaga F; Kulkarni AV; Mousa OY; Arrese M; Arab JP
    Front Med (Lausanne); 2020; 7():448. PubMed ID: 32974366
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Overview of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis Management].
    Kim SK; Kim KI; Kim SR
    Yakugaku Zasshi; 2019; 139(9):1147-1153. PubMed ID: 31474630
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alcohol Consumption and Cardiovascular Outcomes in Patients With Nonalcoholic Fatty Liver Disease: A Population-Based Cohort Study.
    Janjua M; Knuiman M; Divitini M; McQuillan B; Olynyk JK; Jeffrey GP; Adams LA
    Hepatol Commun; 2022 Mar; 6(3):526-534. PubMed ID: 34931492
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of newer antidiabetic drugs on nonalcoholic fatty liver and steatohepatitis: Think out of the box!
    Ranjbar G; Mikhailidis DP; Sahebkar A
    Metabolism; 2019 Dec; 101():154001. PubMed ID: 31672448
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Histopathology of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis.
    Takahashi Y; Fukusato T
    World J Gastroenterol; 2014 Nov; 20(42):15539-48. PubMed ID: 25400438
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.